Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Boule Diagnostics AB (publ)
  6. Summary
    BOUL   SE0011231158

BOULE DIAGNOSTICS AB (PUBL)

(BOUL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
11/23/2021 11/24/2021 11/25/2021 11/26/2021 11/29/2021 Date
53.2(c) 53.9(c) 52.4(c) 51.4(c) 51.4 Last
971 4 930 2 601 4 977 2 140 Volume
-2.39% +1.32% -2.78% -1.91% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2021 438 M 48,2 M 48,2 M
Net income 2021 14,9 M 1,64 M 1,64 M
Net Debt 2021 43,3 M 4,76 M 4,76 M
P/E ratio 2021 65,8x
Yield 2021 0,83%
Sales 2022 523 M 57,5 M 57,5 M
Net income 2022 54,8 M 6,03 M 6,03 M
Net Debt 2022 42,1 M 4,63 M 4,63 M
P/E ratio 2022 18,1x
Yield 2022 1,70%
Capitalization 998 M 110 M 110 M
EV / Sales 2021 2,38x
EV / Sales 2022 1,99x
Nbr of Employees 200
Free-Float 65,8%
More Financials
Company
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing... 
More about the company
Ratings of Boule Diagnostics AB (publ)
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BOULE DIAGNOSTICS AB (PUBL)
11/10Boule Diagnostics AB Q3 presentation
PU
11/10Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months End..
CI
10/22BOULE DIAGNOSTICS : Nomination Committee for the AGM 2022
PU
07/19BOULE DIAGNOSTICS : Q2 presentation
PU
07/19Boule Diagnostics AB Announces Earnings Results for the Quarter Ended June 2021
CI
05/07BOULE DIAGNOSTICS AB (PUBL) : Ex-dividend day for final dividend
FA
05/06Boule Diagnostics AB Publ Reports Earnings Results for the First Quarter Ended March 31..
CI
02/03Boule Diagnostics AB Publ Reports Earnings Results for the Fourth Quarter Ended Decembe..
CI
2020Boule Diagnostics AB Publ Reports Earnings Results for the Third Quarter Ended Septembe..
CI
2020Boule Diagnostics Announces Earnings Results for the Fourth Quarter of 2019
CI
2019BOULE DIAGNOSTICS (PUBL) : Interim report January–September 2019
PU
2019Boule Diagnostics AB Reports Consolidated and Parent Earnings Results for the Second Qu..
CI
2019BOULE DIAGNOSTICS AB : Ex-dividend day for final dividend
FA
2019Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter and Year Ended Dec..
CI
2018Biosurfit, S.A. announced that it expects to receive Ç5 million in funding from Boule D..
CI
More news
News in other languages on BOULE DIAGNOSTICS AB (PUBL)

- No features available -

More news
Chart BOULE DIAGNOSTICS AB (PUBL)
Duration : Period :
Boule Diagnostics AB (publ) Technical Analysis Chart | BOUL | SE0011231158 | MarketScreener
Technical analysis trends BOULE DIAGNOSTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 51,40 SEK
Average target price 70,00 SEK
Spread / Average Target 36,2%
EPS Revisions
Managers and Directors
Jesper S÷derqvist Group President & Chief Executive Officer
Christina Rubenhag Chief Financial Officer & Senior Vice President
Peter von Ehrenheim Chairman
Helena B÷rjesson Chief Technology Officer
Thomas Lennart Eklund Independent Director
Sector and Competitors